Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2026-03-04 @ 8:46 PM
Study NCT ID:
NCT03220958
Status:
COMPLETED
Last Update Posted:
2021-11-09
First Post:
2017-04-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Metoclopramide for Post Traumatic Headache
Sponsor:
Montefiore Medical Center
Organization:
Study Overview
Official Title:
A Randomized Placebo Controlled Trial of IV Metoclopramide for Acute Post-traumatic Headache
Status:
COMPLETED
Status Verified Date:
2021-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Nearly 1.5 million patients present to US emergency departments annually following head trauma. Headache is a frequent symptom of victims of head trauma. The purpose of this study is to see if an intravenous medication called metoclopramide can improve the symptoms of patients with acute post-traumatic headache.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?: